Your session is about to expire
← Back to Search
Remote CGM Monitoring for Type 1 Diabetes
N/A
Waitlist Available
Led By Priya Prahalad, MD, PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age: birth to < 21 years of age
Be younger than 65 years old
Must not have
Diabetes diagnosis other than T1D
Individuals > 21 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Summary
This trial will test whether increased contact between patients and their care team can improve diabetes outcomes. Continuous glucose monitor data will be used to proactively reach out to patients and their families for more frequent dose adjustments.
Who is the study for?
This trial is for children and young adults up to 21 years old who have been newly diagnosed with Type 1 Diabetes within the last month. Participants must be seen at Stanford Children's Diabetes Clinic, agree to share their continuous glucose monitor (CGM) data for remote monitoring, and plan to continue their follow-up care at the same clinic.Check my eligibility
What is being tested?
The study aims to see if more contact between patients and healthcare providers through a system called GluVue can help manage diabetes better in the first year after diagnosis. This involves integrating CGM data into the patient's electronic medical record for closer monitoring.See study design
What are the potential side effects?
Since this trial focuses on remote monitoring of existing CGM devices rather than testing new medications or treatments, there are no direct side effects from interventions being studied.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am younger than 21 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have been diagnosed with a type of diabetes that is not Type 1.
Select...
I am over 21 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Contacts with the care provider
Secondary outcome measures
Hemoglobin A1c
Trial Design
1Treatment groups
Experimental Treatment
Group I: Patients with Type 1 DiabetesExperimental Treatment1 Intervention
Participants will wear a continuous glucose monitor (CGM) and receive remote monitoring of the CGM data by the clinical care team.
Find a Location
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,411 Previous Clinical Trials
17,462,839 Total Patients Enrolled
Priya Prahalad, MD, PhDPrincipal InvestigatorStanford University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been diagnosed with a type of diabetes that is not Type 1.People who have been diagnosed with type 1 diabetes at Stanford Children's Diabetes Clinic within the past month.I am over 21 years old.You can't plan to get check-ups at the Stanford Children's Diabetes Clinic.I was diagnosed with diabetes more than a month ago.I am younger than 21 years old.You plan to get diabetes treatment at a different clinic.
Research Study Groups:
This trial has the following groups:- Group 1: Patients with Type 1 Diabetes
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger